Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia-Reference-Cited by-同舟云学术

Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia

Published:1995-01-26 Issue:4 Volume:332 Page:217-223
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Zittoun Robert A.,Mandelli Franco,Willemze Roel,de Witte Theo,Labar Boris,Resegotti Luigi,Leoni Franco,Damasio Eugenio,Visani Giuseppe,Papa Giuseppe,Caronia Francesco,Hayat Marcel,Stryckmans Pierre,Rotoli Bruno,Leoni Pietro,Peetermans Marc E.,Dardenne Murielle,Vegna Maria Luce,Petti Maria Concetta,Solbu Gabriel,Suciu Stefan

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJM199501263320403

Cited by 770 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50–70 year old AML patients;Bone Marrow Transplantation;2024-09-02

2. Safety and Efficacy of High-Dose Chemotherapy with TreoMel 200 vs. TreoMel 140 in Acute Myeloid Leukemia Patients Undergoing Autologous Stem Cell Transplantation;Cancers;2024-05-15

3. Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia;Hematology, Transfusion and Cell Therapy;2024-04

4. CACA guidelines for holistic integrative management of adult acute myeloid leukemia;Holistic Integrative Oncology;2024-03-14

5. Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT;Bone Marrow Transplantation;2023-08-28